Fig. 1 | Scientific Reports

Fig. 1

From: Vildagliptin modulates the microbiota and induces an immunometabolic profile compatible with neuroprotection in type 2 diabetes

Fig. 1

Vildagliptin effects on glycemia, HbA1c, and HOMA-IR over time (0 and 60 days). Data points represent mean values, with error bars indicating standard deviation. Statistical comparisons between time points are shown, with p values indicating significant differences: Glycemia: Significant reduction from day 0 to 60 (p = 0.0194). HbA1c: Significant decrease from day 0 to 60 (p = 2.85e−07). HOMA-IR: Significant difference from day 0 to 60 (p = 0.0492).

Back to article page